News for 'New Drugs Advisory Committee'

Centre Tightens Rules on Alcohol-Based Medicines

Centre Tightens Rules on Alcohol-Based Medicines

Rediff.com11 Jul 2026

The move follows reports from several state drug-regulatory authorities indicating misuse and hoarding oral formulations with high ethyl-alcohol concentration, which people use as a substitute for liquor.

Why Kiran Mazumdar-Shaw Wants Niece Claire To Take Over

Why Kiran Mazumdar-Shaw Wants Niece Claire To Take Over

Rediff.com18 May 2026

'Leadership is about understanding how a business works, how it is shaped, built, and expanded.'

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Cough Medicine Deaths: Rajasthan Suspends Drug Controller

Rediff.com4 Oct 2025

The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Kaysons Pharma following reports of children's deaths allegedly linked to contaminated cough syrup.

Monitor NDMA levels in Ranitidine: Drug regulator to states

Monitor NDMA levels in Ranitidine: Drug regulator to states

Rediff.com29 Jul 2025

Drug regulator DCGI has asked drug controllers of all states and Union Territories to direct manufacturers under their jurisdiction to monitor the presence of a potentially carcinogenic chemical -- N-Nitrosodimethylamine -- in antacid Ranitidine.

Centre bans 156 drugs used for fever, pain, allergies

Centre bans 156 drugs used for fever, pain, allergies

Rediff.com22 Aug 2024

FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also referred to as 'cocktail' drugs.

States Seek Centre's Help To Deal With Trump's Tariffs

States Seek Centre's Help To Deal With Trump's Tariffs

Rediff.com2 Sep 2025

State governments have requested the Centre for export incentives, lifting of import duty in the case of cotton for the textile sector and GST exemptions.

Govt moves to ease business rules, tables Jan Vishwas Bill in LS

Govt moves to ease business rules, tables Jan Vishwas Bill in LS

Rediff.com18 Aug 2025

The Jan Vishwas (Amendment of Provisions) Bill 2025, aimed at decriminalizing minor offenses to promote ease of living and business, was introduced in the Lok Sabha and referred to a Select Committee.

Why India's medical device makers are moving to Vietnam, Malaysia

Why India's medical device makers are moving to Vietnam, Malaysia

Rediff.com14 Mar 2025

A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes, according to the Parliamentary Standing Committee on Health and Family Welfare.

Govt to review suspension of 3 drugs

Govt to review suspension of 3 drugs

Rediff.com10 Jul 2013

Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.

Govt issues advisory for rational use of Remdesivir

Govt issues advisory for rational use of Remdesivir

Rediff.com7 Jun 2021

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.

Kash Patel likely to become acting ATF chief

Kash Patel likely to become acting ATF chief

Rediff.com23 Feb 2025

Patel has previously worked at the justice department as a trial attorney for three years before taking on roles at the National Security Council, the office of the director of National Intelligence, and the department of defence, the report said.

Pharma crusader takes India's drug regulators to court

Pharma crusader takes India's drug regulators to court

Rediff.com7 Mar 2016

Dinesh Thakur is famous for exposing Ranbaxy safety problems

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Mumbai hospitals await FDA guidance on Ranbaxy drugs

Rediff.com10 Jun 2013

Earlier, Jaslok Hospital had issued an advisory to its doctors to avoid prescribing drugs manufactured by Ranbaxy.

Pfizer Covid vaccine gets US experts' nod

Pfizer Covid vaccine gets US experts' nod

Rediff.com11 Dec 2020

The Pfizer vaccine has already been approved for the public in the United Kingdom and, Canada.

Winter session begins today, farm law repeal among 26 bills on agenda

Winter session begins today, farm law repeal among 26 bills on agenda

Rediff.com29 Nov 2021

The government's agenda also includes the Cryptocurrency and Regulation of Official Digital Currency Bill, 2021.

Pharma firms might resume sales of analgin-based drugs

Pharma firms might resume sales of analgin-based drugs

Rediff.com24 Dec 2013

The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.

328 fixed-dose combination drugs banned on safety grounds

328 fixed-dose combination drugs banned on safety grounds

Rediff.com14 Sep 2018

The original list had named 349 drugs, but 15 drugs, approved prior to 1988, have been kept outside the purview of the ban

Pharma firms face ban on Merck generic

Pharma firms face ban on Merck generic

Rediff.com16 Apr 2007

Over 30 domestic pharmaceutical companies, including Ranbaxy, Cipla, Nicholas Piramal, Zydus Cadila and Torrent, face a possible ban on the sale of the generic version of Merck's pain management drug in the Indian market.

Over 340 drugs to go off the shelves soon

Over 340 drugs to go off the shelves soon

Rediff.com26 Jul 2018

Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma).

New-Gen COVID Jabs Coming Soon...

New-Gen COVID Jabs Coming Soon...

Rediff.com28 May 2024

India currently does not have any XBB 1.5 variant-based vaccines available.

US regulators recommend pause on J&J vaccine over rare blood clots

US regulators recommend pause on J&J vaccine over rare blood clots

Rediff.com13 Apr 2021

In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count.

SIIto test Novavax's Omicron-specific vaccine

SIIto test Novavax's Omicron-specific vaccine

Rediff.com6 Jun 2022

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for 'examination, test, and analysis', reports Sohini Das.

Monsoon session of Parliament begins today, set to be stormy

Monsoon session of Parliament begins today, set to be stormy

Rediff.com20 Jul 2023

Parliamentary Affairs Minister Prahlad Joshi has said that 31 bills will be taken up in the monsoon session. Among these include the Digital Personal Data Protection Bill, 2023.

Drug makers oppose ban on diabetes pill

Drug makers oppose ban on diabetes pill

Rediff.com3 Jul 2013

Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.

Senate confirms Dr Vivek Murthy as US Surgeon General

Senate confirms Dr Vivek Murthy as US Surgeon General

Rediff.com24 Mar 2021

Dr Murthy, 43, would occupy the position of America's Surgeon General for the second time. In 2011, president Barack Obama tapped him to serve on the advisory group on prevention, health promotion, and integrative and public health.

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Ethical Code to keep doctor, drugmaker nexus at bay not mandatory yet

Rediff.com22 Aug 2022

'Gift-giving' - from free dinners and drug samples to promotional merchandise - seems to be driving drugmakers' marketing - a marketing prescription deeply entrenched in the industry. This is a well-oiled racket that sees pharmaceutical (pharma) companies 'gifting' doctors to push their respective drugs under the guise of marketing. But is there a cure in sight to end this unhealthy alliance? The recent controversy following the income-tax raids on Bengaluru-based drugmaker Micro Labs, makers of popular paracetamol brand Dolo-650, has brought this to the fore, again.

Govt panel recommends reducing Covid booster dose gap to 6 months

Govt panel recommends reducing Covid booster dose gap to 6 months

Rediff.com16 Jun 2022

The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.

US sets new record with over 3,000 COVID deaths in 1 day

US sets new record with over 3,000 COVID deaths in 1 day

Rediff.com10 Dec 2020

The previous single-day record was on May 7 at 2,769 deaths.

'New Covid surge is a seasonal wave but spreads faster'

'New Covid surge is a seasonal wave but spreads faster'

Rediff.com18 Mar 2024

'Seek medical help if after five days of the first symptom the fever has not subsided.'

US: First batch of COVID-19 vaccine roll out of Pfizer plant

US: First batch of COVID-19 vaccine roll out of Pfizer plant

Rediff.com14 Dec 2020

The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.

Are You Eligible For A Booster Shot?

Are You Eligible For A Booster Shot?

Rediff.com27 Dec 2021

'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'

US authorises Moderna vaccine for emergency use

US authorises Moderna vaccine for emergency use

Rediff.com19 Dec 2020

According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).

Covaxin gets nod for use in children above 12 years with riders

Covaxin gets nod for use in children above 12 years with riders

Rediff.com25 Dec 2021

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

Toxins in cough syrups, other drugs due to plastic bottling

Toxins in cough syrups, other drugs due to plastic bottling

Rediff.com1 Jun 2016

Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

Covaxin emergency use decision likely in 4-6 weeks: WHO

Covaxin emergency use decision likely in 4-6 weeks: WHO

Rediff.com10 Jul 2021

There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group," Swaminathan said.

India may be entering endemic stage of Covid: WHO chief scientist

India may be entering endemic stage of Covid: WHO chief scientist

Rediff.com24 Aug 2021

The endemic stage is when a population learns to live with a virus.

Opposition seeks compensation for migrants who died during lockdown

Opposition seeks compensation for migrants who died during lockdown

Rediff.com16 Sep 2020

Several opposition members, including from the Dravida Munnetra Kazagham and the Communist Party of India-Marxist, also pointed out that the government took almost two months to impose the lockdown after the first case came to light in January, and claimed the delay had proved costly.